Published January 15, 2009 | Version Accepted Version + Supplemental Material
Journal Article Open

Catalytic enantioselective approach to the eudesmane sesquiterpenoids: total synthesis of (+)-carissone

  • 1. ROR icon California Institute of Technology

Abstract

A catalytic enantioselective approach to the eudesmane sesquiterpenoids is reported. The strategic use of a palladium-catalyzed enantioselective alkylation of vinylogous ester substrates forged the C(10) all-carbon quaternary center. This key transformation enabled a diastereoselective olefin hydrogenation to create the syn stereochemistry at C(7). The devised synthetic strategy allowed for the preparation of the antibacterial agent (+)-carissone and a formal synthesis of the P/Q-type calcium channel blocker (-)-α-eudesmol.

Additional Information

© 2008 American Chemical Society. Received October 19, 2008. We thank Krastina V. Petrova and Justin T. Mohr (Caltech) for helpful discussions and experimental assistance. We gratefully acknowledge the NIH-NIGMS (RO1GM080269-01), Marcella R. Bonsall and the Dalton Fund (undergraduate fellowships to S.R.L.), Eli Lilly (predoctoral fellowship to M.R.K.), Amgen, Abbott Laboratories, Boehringer-Ingelheim, Materia, Merck, Bristol-Meyers Squibb, and the California Institute of Technology for financial support.

Attached Files

Accepted Version - nihms110342.pdf

Supplemental Material - LEVol09supp.pdf

Files

LEVol09supp.pdf

Files (3.4 MB)

Name Size
md5:fdb56952f990ff64748855af07530496
2.9 MB Preview Download
md5:1c192e55dd64566a4ab68e547db43c76
504.3 kB Preview Download

Additional details

Identifiers

PMCID
PMC2724392
Eprint ID
13592
DOI
10.1021/ol802409h
Resolver ID
CaltechAUTHORS:LEVol09

Related works

Describes
10.1021/ol802409h (DOI)

Funding

NIH
RO1GM080269-01
Dalton Fund
Eli Lilly
Amgen
Abbott Laboratories
Boehringer-Ingelheim
Materia, Inc.
Merck
Bristol-Myers Squibb
Caltech

Dates

Created
2009-05-12
Created from EPrint's datestamp field
Updated
2021-11-08
Created from EPrint's last_modified field